Having received U.S. and European approval earlier this year, Boston Scientific is launching the Interlock – 35 Fibered IDC Occlusion System. The device is designed to provide more control and precision and is formally indicated for “obstructing or reducing blood flow in the peripheral vasculature during embolization procedures.”
The Interlock – 35 System consists of a 0.035″ detachable coil that features a unique interlocking connection between the coil and delivery wire designed to offer excellent placement control, including the ability to advance, retract and reposition the coil before final deployment in the vessel. The coil is engineered to be accurately and reliably detached by simply pushing the detachment zone beyond the distal end of the 5F delivery catheter. The platinum coil is constructed with a dense network of synthetic fibers, designed to offer excellent thrombogenicity (blockage of blood flow) and rapid stasis.
The Interlock – 35 Fibered IDC Occlusion System is available in 31 configurations that include coil lengths from 4 cm to 40 cm, diameters from 3 mm to 20 mm, and three distinct shapes (Cube, 2D Helical and Diamond) to offer physicians greater flexibility to treat diverse vessel anatomy. When combined with Boston Scientific’s market-leading 0.018″ Interlock Fibered IDC Coils, the Interlock Coil portfolio provides 50 different coils to optimize peripheral embolization procedures.
Product page: Interlock™ Fibered IDC™ Occlusion System …